Covidien — Merger or Acquisition (July 2014)
26 slides from Covidien's merger presentation, Jul 31, 2014
Slide 1: Town Hall Meeting
Town Hall Meeting July 31, 2014 Omar Ishrak Chairman and CEO Medtronic, Inc. Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form
Slide 2: Medtronic to Acquire Covidien
Medtronic to Acquire Covidien Creates the premier global medical technology and services company with unmatched breadth and patient reach
Slide 3: About Medtronic
About Medtronic
Slide 4: Fulfilling Unmet Medical Needs
Fulfilling Unmet Medical Needs
Slide 5: The Medtronic Mission: A Shared Sense of Purpose
The Medtronic Mission: A Shared Sense of Purpose To contribute to human welfare…alleviate pain, restore health, and extend life… To direct our growth in the areas of maximum strength and ability…to continuously build on these areas through education and knowledge… To strive without reserve for the g
Slide 6: Universal Healthcare Needs
Improve Clinical Outcomes Expand Access Optimize Cost and Efficiency Universal Healthcare Needs
Slide 7: Strategies to Address Healthcare Needs
Economic Value Globalization Strategies Therapy Innovation Universal HC needs Improve clinical outcomes Expand access Optimize cost and efficiency Strategies to Address Healthcare Needs
Slide 8: Three Business Groups Address Broad Spectrum of Diseases
Three Business Groups Address Broad Spectrum of Diseases The data in this chart has been intentionally rounded to the nearest whole percentage and therefore does not sum to 100%. Cardiac Rhythm & Heart Failure 30% Coronary & Structural Heart 18% Aortic & Peripheral 5% Diabetes 9% Surgical Technologi
Slide 9: Strategic Fit
Strategic Fit
Slide 10: Combination Results in Strategic Diversification
Combination Results in Strategic Diversification Surgical Solutions Respiratory & Patient Care Surgical Solutions Respiratory & Patient Care
Slide 11: A Strong Strategic Fit
Delivering strong launch cadence of meaningful therapies and procedures Addressing the inequities in healthcare access globally Becoming a leader in value-based healthcare by incorporating EV into our DNA Uniquely positioned to expand our industry- leading franchises through our three differentiated
Slide 12: Three Key Benefits for Medtronic and Covidien
Three Key Benefits for Medtronic and Covidien Therapy Innovation Therapy Innovation 1. Strengthen and enhance Peripheral Vascular and Neuroscience portfolios 2. Leverage adjacencies in Medtronic Surgical Technologies and Covidien Surgical Solutions 3. Accelerate market adoption of early stage Covidi
Slide 13: Covidien Expertise Creates Broader Offering in Peripheral Vascular Disease Management
Covidien Expertise Creates Broader, More Compelling Offering in Peripheral Vascular Disease Management Strength in Aortic Disease Management Strength and Product Breadth in Peripheral Vascular Disease Management Combined Businesses Will Provide Opportunity to Accelerate Growth Augmented by Therapy I
Slide 14: Combined Company Immediately Accelerates Ability to Expand Global Access
Combined Company Immediately Accelerates Ability to Expand Global Access countries 150 + locations 300 + combined EM revenue $3.7B Broader presence facilitates more rapid expansion Covidien products such as surgical tools and capital equipment are adopted earlier in hospitals, becoming a base for Me
Slide 15: Opportunities to Become Robust Integrated Health Solutions Partner
Cath Lab Managed Services (Europe) Cardiac & Vascular Line Administrator (U.S.) General Surgery Line Administrator (U.S.) General Surgery Managed Services (Europe) Opportunities to Become Robust Unmatched Integrated Health Solutions Partner Economic Value Cardiocom Covidien Sensors Value primarily r
Slide 16: Integration Guidelines
Integration Guidelines
Slide 17: Guiding Principles for Integration
Guiding Principles for Integration • Continue to act as independent companies until transaction close • Keep focus and protect current business momentum in our respective companies • Plan for integration now to be ready for Day 1 post-close • Focus on creating lasting value beyond stated cost synerg
Slide 18: Integration Team Structure
Integration Team Structure Medtronic Medtronic Geoff Martha Bill Burke Medtronic Steering Committee Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Cross-functional teams Commercial teams Functional teams Med
Slide 19: Combined Impact
Combined Impact
Slide 20: Accelerating Covidien Early Stage Therapies
Accelerating Covidien Early Stage Therapies Interventional Lung: For Lung Cancer Interventional GI (Barrett's): For Barrett's Esophagus (pre-cancerous) Stroke: SWIFT PRIME Clinical Trial Open to Minimally Invasive Surgery: e.g. Bariatric Minimally Invasive Surgery Capnography: CO Monitoring 2
Slide 21: Transforming Healthcare Around the World to Improve More Lives Together
Transforming Healthcare Around the World to Improve More Lives Together: Every seconds $27 Billion Healthcare Leader 87,000+ Employees Life-Changing Impact for Millions of Patients
Slide 22: Q&A
Q&A ?
Slide 23: No Offer or Solicitation
NO OFFER OR SOLICITATION This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the
Slide 24: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements Statements contained in this communication that refer to New Medtronic’s, Medtronic's and/or Covidien’s estimated or anticipated future results, including estimated synergies, or other non-historical facts are forward-looking statements that
Slide 25: Statement Required by the Irish Takeover Rules
Statement Required by the Irish Takeover Rules The directors of Medtronic accept responsibility for the information contained in this document. To the best of the knowledge and belief of the directors of Medtronic (who have taken all reasonable care to ensure that such is the case), the information
Slide 26: Town Hall Meeting
Town Hall Meeting Omar Ishrak Chairman and CEO Medtronic, Inc.